Browsing Category
Pharma Industry News
4753 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
NLS Pharmaceutics and Kadimastem merger aims to redefine diabetes treatment with multi-target therapies
NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company specialising in therapies for rare and complex central nervous system…
Medincell’s Phase 3 trial for long-acting injectable olanzapine in schizophrenia reaches completion
Medincell has announced the successful completion of the pivotal Phase 3 SOLARIS clinical trial for its long-acting injectable…
Cencora strengthens pharmaceutical supply chain with expanded drug shortage mitigation program
Cencora, a leading global healthcare solutions company, has announced a major expansion of its drug shortage mitigation initiative,…
Novo Nordisk’s Mim8 shows promising efficacy and safety in haemophilia A children, phase 3 interim results reveal
Novo Nordisk A/S has announced encouraging interim results from its phase 3 FRONTIER3 clinical trial, highlighting the potential…
AstraZeneca reports strong FY 2024 results with robust revenue growth driven by oncology and biopharmaceuticals
AstraZeneca’s financial performance for fiscal year 2024 reflects impressive growth, with the pharmaceutical giant reporting a 21% surge…
FDA approves EMBLAVEO to combat complicated intra-abdominal infections with limited treatment options
The U.S. Food and Drug Administration (FDA) has granted approval for EMBLAVEO (aztreonam and avibactam), marking a significant…
Novartis achieves 22% rise in core operating income, driven by innovative medicines
Novartis has reported a stellar performance for the fourth quarter of 2024, showcasing impressive growth across its core…
Merck initiates Phase 3 waveLINE-010 trial for zilovertamab vedotin in diffuse large B-cell lymphoma
Merck, known as MSD outside the United States and Canada, has launched its pivotal Phase 3 waveLINE-010 clinical…
Roche’s Gazyva shows superior efficacy in lupus nephritis treatment, Phase III trial data reveals
Roche has announced promising new data from its phase III REGENCY clinical trial, published in the New England…
Janssen’s subcutaneous amivantamab gains CHMP backing for EGFR-mutated lung cancer
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a…